~~<i id='13D61A30F3'><strike id='13D61A30F3'><tt id='13D61A30F3'><pre id='13D61A30F3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

Wikipedia

author：hotspot 2025-09-01 06:06:25 - browse：27

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： FDA moves to stop vape shops from selling Elf Bar, Esco Bars

hotspot

leisure time

focus

explore

focus

explore

PatGreenhouse/GlobeStaffMORRISVILLE,N.C.—TenminutesfromtheRaleighairport,thefutureofbiotechisunderco

WSS

Readout Newsletter: The latest on Novavax, Merck, Bluebird

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

FTC sues over Novant Health acquisition of two N.C. hospitals

Sanofi seeks simpler, safer CRISPR sickle cell cure

Philips to halt sales of sleep apnea machines in U.S.

A public scorecard can help hold safety

knowledge

Wikipedia

hotspot

Hollywood unions extend contract negotiations for actors

Biogen walks away from Aduhelm, years after polarizing approval

Hollywood unions extend contract negotiations for actors

Vertex non

Psychedelics group wrestles with new pharma identity

White House pharmacy plagued with problems, investigation finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In early work, researchers turn to CRISPR to treat Alzheimer's

Alkermes shareholders re

How generative AI ratchets up security threats for health systems

leisure time

Group opposing PBM reform sets lobbying record

Merck, Johnson & Johnson CEOs will testify on high drug prices

10 reasons why health care startups fail

Why hospitals are withdrawing from US News rankings

Sanders adds drug shortage policies to pandemic preparedness bill

Zyn nicotine pouches become unlikely player in latest culture war

focus

explore

focus

explore